Direct to Provider & Hand Carry Samples: Medvantx Expands Access with RxS Acquisition
In today’s evolving pharmaceutical landscape, the ability to deliver therapies efficiently and compliantly is more critical than ever. Medvantx is leading the way with an enhanced Samples Program, now offering both direct to provider samples and hand carry samples through the strategic acquisition of RxS. This integration is transforming how healthcare providers access and distribute prescription samples—ultimately improving patient access and outcomes.
Bridging the Gap Between Providers and Patients
With over 25 years of experience in pharmaceutical logistics and compliance, Mark Jara, Senior Vice President of the Samples Platform, brings a wealth of knowledge to Medvantx. His leadership is instrumental in aligning direct to provider samples and hand carry samples with Medvantx’s mission to expand access to care.
“RxS is focused on the healthcare provider side—getting samples into the hands of HCPs—while Medvantx has been a leader in direct-to-patient access,” Mark explains. “Together, we now offer a full-spectrum solution that supports both trial and adherence.”
Technology-Driven Sampling Innovation
At the core of this transformation is LinkedRx, a proprietary platform that consolidates multiple sampling channels—including hand carry samples, direct to provider Samples, e-sampling, and inside sales—into a single, compliant hub. “LinkedRx is our system of record,” Mark says. “It enables automated business rules, ensures PDMA compliance, and provides clients with strategic insights across all sampling channels.” This centralized approach empowers pharmaceutical companies to manage their samples program with greater visibility, efficiency, and compliance.
Medvantx’s samples program is purpose-built for PDMA adherence, with automated safeguards and audit-ready reporting. These compliance features are especially critical for direct to provider & hand carry samples, where regulatory oversight is essential.
“Every sales rep is essentially a mini-warehouse,” Mark notes. “We monitor sample distribution at that level of granularity, which gives finance, operations, and manufacturing teams the data they need to manage costs, optimize supply, and ensure regulatory alignment.” With DTP, we streamline delivery straight to the practitioner’s office,” Mark adds. “It ensures faster access, tighter inventory control, and a cleaner chain of custody—especially critical in today’s compliance-driven environment.” Mark’s role on the PDMA Sharing Alliance board and his recognition as a PharmaVoice 100 Compliance Innovator reinforces Medvantx’s leadership in this space.
Differentiation Through Flexibility
What sets Medvantx’ pharmacy apart is its ability to adapt. The samples program is integrated with major CRMs, logistics providers, and data warehouses, allowing clients to tailor their samples dispensing strategies without compromising on compliance. “We’re not a cookie-cutter solution,” Mark emphasizes. “We adapt to our clients’ needs while maintaining the rigor that compliance demands.”
Perhaps the most exciting outcome of this acquisition is the ability to support the full lifecycle of patient access—from provider trial to patient adherence. “We help providers introduce therapies through samples, and then support patients directly through fulfillment and adherence programs,” Mark says. “It’s a closed-loop model that no one else in the market is offering at this scale.”
Looking Ahead in Direct to Provider & Hand Carry Samples
As Medvantx continues to grow, its samples program is setting a new standard for compliant, flexible, and patient-centered pharmaceutical sampling. Whether through direct to provider samples and hand carry samples, or integrated digital engagement, Medvantx is committed to expanding access and improving outcomes.
–
Learn more about Medvantx’s innovative samples program and how it’s driving access and equity in healthcare:
https://medvantx.com/flexible-and-compliant-sampling-programs/
